76 related articles for article (PubMed ID: 9144255)
1. Inhibitors of Cyclophilin A: Current and Anticipated Pharmaceutical Agents for Inflammatory Diseases and Cancers.
Zhao X; Zhao X; Di W; Wang C
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542872
[TBL] [Abstract][Full Text] [Related]
2. Prolyl isomerization controls activation kinetics of a cyclic nucleotide-gated ion channel.
Schmidpeter PAM; Rheinberger J; Nimigean CM
Nat Commun; 2020 Dec; 11(1):6401. PubMed ID: 33328472
[TBL] [Abstract][Full Text] [Related]
3. Screening of the Active Component Promoting Leydig Cell Proliferation from
Gao XC; Lv JW; Li CN; Zhang NX; Tian LL; Han XY; Zhang H; Sun JM
Molecules; 2019 Jun; 24(11):. PubMed ID: 31163647
[No Abstract] [Full Text] [Related]
4. Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.
Cho KI; Patil H; Senda E; Wang J; Yi H; Qiu S; Yoon D; Yu M; Orry A; Peachey NS; Ferreira PA
J Biol Chem; 2014 Feb; 289(8):4600-25. PubMed ID: 24403063
[TBL] [Abstract][Full Text] [Related]
5. Cyclophilin A: a key player for human disease.
Nigro P; Pompilio G; Capogrossi MC
Cell Death Dis; 2013 Oct; 4(10):e888. PubMed ID: 24176846
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, maturation, and trafficking of human Na+-dicarboxylate cotransporter NaDC1 requires the chaperone activity of cyclophilin B.
Bergeron MJ; Bürzle M; Kovacs G; Simonin A; Hediger MA
J Biol Chem; 2011 Apr; 286(13):11242-53. PubMed ID: 21257749
[TBL] [Abstract][Full Text] [Related]
7. The 5-HT3 receptor--the relationship between structure and function.
Barnes NM; Hales TG; Lummis SC; Peters JA
Neuropharmacology; 2009 Jan; 56(1):273-84. PubMed ID: 18761359
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin regulation in fungi and beyond.
Stie J; Fox D
Eukaryot Cell; 2008 Feb; 7(2):177-86. PubMed ID: 18065652
[No Abstract] [Full Text] [Related]
9. One novel quinoxaline derivative as a potent human cyclophilin A inhibitor shows highly inhibitory activity against mouse spleen cell proliferation.
Li J; Chen J; Zhang L; Wang F; Gui C; Zhang L; Qin Y; Xu Q; Liu H; Nan F; Shen J; Bai D; Chen K; Shen X; Jiang H
Bioorg Med Chem; 2006 Aug; 14(16):5527-34. PubMed ID: 16682211
[TBL] [Abstract][Full Text] [Related]
10. Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release.
Guo HX; Wang F; Yu KQ; Chen J; Bai DL; Chen KX; Shen X; Jiang HL
Acta Pharmacol Sin; 2005 Oct; 26(10):1201-11. PubMed ID: 16174436
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment.
Cottet-Maire F; Avdonin PV; Roulet E; Buetler TM; Mermod N; Ruegg UT
Br J Pharmacol; 2001 Feb; 132(4):909-17. PubMed ID: 11181432
[TBL] [Abstract][Full Text] [Related]
12. alpha-bungarotoxin receptors contain alpha7 subunits in two different disulfide-bonded conformations.
Rakhilin S; Drisdel RC; Sagher D; McGehee DS; Vallejo Y; Green WN
J Cell Biol; 1999 Jul; 146(1):203-18. PubMed ID: 10402471
[TBL] [Abstract][Full Text] [Related]
13. The role of immunophilins in mutant superoxide dismutase-1linked familial amyotrophic lateral sclerosis.
Lee JP; Palfrey HC; Bindokas VP; Ghadge GD; Ma L; Miller RJ; Roos RP
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3251-6. PubMed ID: 10077670
[TBL] [Abstract][Full Text] [Related]
14. Cell surface expression of the Alzheimer disease-related presenilin proteins.
Dewji NN; Singer SJ
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9926-31. PubMed ID: 9275228
[TBL] [Abstract][Full Text] [Related]
15. Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression.
Helekar SA; Patrick J
Proc Natl Acad Sci U S A; 1997 May; 94(10):5432-7. PubMed ID: 9144255
[TBL] [Abstract][Full Text] [Related]
16. Prolyl isomerase requirement for the expression of functional homo-oligomeric ligand-gated ion channels.
Helekar SA; Char D; Neff S; Patrick J
Neuron; 1994 Jan; 12(1):179-89. PubMed ID: 7507339
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A.
Ke H; Mayrose D; Belshaw PJ; Alberg DG; Schreiber SL; Chang ZY; Etzkorn FA; Ho S; Walsh CT
Structure; 1994 Jan; 2(1):33-44. PubMed ID: 8075981
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity.
Hong F; Lee J; Piao YJ; Jae YK; Kim YJ; Oh C; Seo JS; Yun YS; Yang CW; Ha J; Kim SS
Biochem Biophys Res Commun; 2004 Apr; 316(4):1073-80. PubMed ID: 15044094
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of immunosuppression by cyclosporins.
Zenke G; Baumann G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH
Ann N Y Acad Sci; 1993 Jun; 685():330-5. PubMed ID: 7689806
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
